These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study. Kim CJ, Yoon HK, Park MJ, Yoo KH, Jung KS, Park JW, Lim SY, Shim JJ, Lee YC, Kim YS, Oh YM, Kim S, Yoo CG. Int J Chron Obstruct Pulmon Dis; 2017 Dec; 12():1589-1596. PubMed ID: 28615931 [Abstract] [Full Text] [Related]
8. Efficacy and safety of indacaterol in patients with chronic obstructive pulmonary disease aged over 65 years: A pooled analysis. Girodet PO, Jasnot JY, Le Gros V, Decuypère L, Cao W, Devouassoux G. Respir Med; 2017 Jul; 128():92-101. PubMed ID: 28566230 [Abstract] [Full Text] [Related]
10. Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use. Decramer M, Dahl R, Kornmann O, Korn S, Lawrence D, McBryan D. Respir Med; 2013 Feb; 107(2):223-32. PubMed ID: 23219347 [Abstract] [Full Text] [Related]
12. Assessment of acute bronchodilator effects from specific airway resistance changes in stable COPD patients. Santus P, Radovanovic D, Henchi S, Di Marco F, Centanni S, D'Angelo E, Pecchiari M. Respir Physiol Neurobiol; 2014 Jun 15; 197():36-45. PubMed ID: 24726342 [Abstract] [Full Text] [Related]
18. Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease. Nishijima Y, Minami S, Yamamoto S, Ogata Y, Koba T, Futami S, Komuta K. Int J Chron Obstruct Pulmon Dis; 2015 Jun 15; 10():439-44. PubMed ID: 25767381 [Abstract] [Full Text] [Related]
19. Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data. Bleecker ER, Siler T, Owen R, Kramer B. Int J Chron Obstruct Pulmon Dis; 2011 Jun 15; 6():431-8. PubMed ID: 22003288 [Abstract] [Full Text] [Related]
20. Assessing efficacy of indacaterol in moderate and severe COPD patients: a 12-week study in an Asian population. To Y, Kinoshita M, Lee SH, Hang LW, Ichinose M, Fukuchi Y, Kitawaki T, Okino N, Prasad N, Lawrence D, Kramer B. Respir Med; 2012 Dec 15; 106(12):1715-21. PubMed ID: 23040786 [Abstract] [Full Text] [Related] Page: [Next] [New Search]